A pharmaceutical company decides to go global for a lot of reasons: Perhaps they want to expand into developing markets that are less saturated. Or they may need to conduct global clinical trials to get broader and more diverse participant base.
Whatever the reason, a company does not make that decision without being certain of significant revenue opportunities, quality improvements, or time savings. Or all three.
But while going global opens up a whole new world of opportunity for pharmaceutical companies, it also creates new and unique challenges. Continue reading at Pharmaceutical Compliance Monitor